AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
EN
Login
EN
Plunge Analysis
/
Eterna Therapeutics Inc.
/
2026-04-30
▼ PLUNGE
Eterna Therapeutics Inc.
-22.3%
ERNA
NASDAQ
Healthcare
2026-04-30
0.148
Close
0.19
Prev Close
-22.32%
Change
15.2x
Vol Ratio
Why It Plunged
No related news available.
Related News
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria
Weeklyvoice
2026-04-13
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan
2026-04-06
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus
2026-04-06
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
Weeklyvoice
2026-04-06
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular ...
Postregister
2026-04-16
Technical Analysis
Signals
BB Lower Break
Oversold
MACD Bearish
Below SMA20
Key Indicators
24.14
RSI (14)
0.20
SMA 20
0.17
Bollinger Lower
0.23
Bollinger Upper
0.20
Bollinger Mid
-0.02
MACD
-0.02
MACD Signal
0.00
MACD Hist
View Company
Back to Surge Stocks
Eterna Therapeutics Inc. Surged +-22.3% on 2026-04-30 — Analysis | Alpha Lenz